Literature DB >> 20045358

Serum concentrations of buprenorphine after oral and parenteral administration in male mice.

Otto Kalliokoski1, Kirsten R Jacobsen, Jann Hau, Klas S P Abelson.   

Abstract

Buprenorphine is the most commonly used drug for peri-operative pain relief in laboratory rodents. The systemic concentrations of buprenorphine were measured in mice following administration intravenously (i.v.), subcutaneously (s.c.), orally by gavage and by voluntary ingestion, to determine the post-administration serum concentration of buprenorphine. Voluntarily ingested buprenorphine resulted in long-lasting high serum concentrations, as did oral gavage administration (24 h serum concentration: 110 ng h/mL for both routes of administration). In contrast, buprenorphine administered parenterally remained in the circulation for a substantially shorter time (24 h serum concentration for i.v. and s.c. were 40 ng h/mL and 30 ng h/mL, respectively). This marked difference was probably due to the higher dose used for oral administration, which is regarded necessary for sufficient analgesic effect, and to the slower absorption of the oral boli, as well as saturation of the hepatic buprenorphine metabolising pathways. Voluntary ingestion of buprenorphine was found to constitute a practical way to provide laboratory mice with efficient pain relief.
Copyright © 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20045358     DOI: 10.1016/j.tvjl.2009.11.013

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  17 in total

1.  Ovariectomy and 17β-estradiol replacement in rats and mice: a visual demonstration.

Authors:  Jakob O Ström; Annette Theodorsson; Edvin Ingberg; Ida-Maria Isaksson; Elvar Theodorsson
Journal:  J Vis Exp       Date:  2012-06-07       Impact factor: 1.355

2.  Pharmacokinetics of sustained-release analgesics in mice.

Authors:  Lon V Kendall; Ryan J Hansen; Kathryn Dorsey; Sooah Kang; Paul J Lunghofer; Daniel L Gustafson
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-09       Impact factor: 1.232

3.  Antinociceptive effects of sustained-release buprenorphine in a model of incisional pain in rats (Rattus norvegicus).

Authors:  Helen H Chum; Katechan Jampachairsri; Gabriel P McKeon; David C Yeomans; Cholawat Pacharinsak; Stephen A Felt
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-03       Impact factor: 1.232

4.  Voluntary Oral Administration of Losartan in Rats.

Authors:  Lucília N Diogo; Inês V Faustino; Ricardo A Afonso; Sofia A Pereira; Emília C Monteiro; Ana I Santos
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-09       Impact factor: 1.232

5.  Analgesic Efficacy of Subcutaneous-Oral Dosage of Tramadol after Surgery in C57BL/6J Mice.

Authors:  Rocio Evangelista-Vaz; Alessandra Bergadano; Margarete Arras; Paulin D Jirkof
Journal:  J Am Assoc Lab Anim Sci       Date:  2018-06-05       Impact factor: 1.232

6.  Colon anastomotic leakage: improving the mouse model.

Authors:  Hans-Christian Pommergaard; Michael Patrick Achiam; Jacob Rosenberg
Journal:  Surg Today       Date:  2013-06-09       Impact factor: 2.549

7.  Effects of buprenorphine and estrous cycle in a murine model of cecal ligation and puncture.

Authors:  Lucy H Kennedy; Haejin Hwang; A Marissa Wolfe; Joseph Hauptman; Jean A Nemzek-Hamlin
Journal:  Comp Med       Date:  2014-08       Impact factor: 0.982

8.  Effects of buprenorphine and meloxicam analgesia on induced cerebral ischemia in C57BL/6 male mice.

Authors:  Kirsten R Jacobsen; Natasha Fauerby; Zindy Raida; Otto Kalliokoski; Jann Hau; Flemming F Johansen; Klas Sp Abelson
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

9.  Pharmacokinetic Profiles of Nalbuphine after Intraperitoneal and Subcutaneous Administration to C57BL/6 Mice.

Authors:  Brenda L Kick; Pan Shu; Bo Wen; Duxin Sun; Douglas K Taylor
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-09-01       Impact factor: 1.232

10.  Evaluation of buprenorphine hydrochloride Pluronic(®) gel formulation in male C57BL/6NCrl mice.

Authors:  Terry L Blankenship-Paris; John W Dutton; David R Goulding; Christopher A McGee; Grace E Kissling; Page H Myers
Journal:  Lab Anim (NY)       Date:  2016-09-21       Impact factor: 12.625

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.